Does Radiation-Induced Abrogation of Skin Langerhans Cell Functions Lead to Enhanced Incidence of Skin Tumors in Patients with Genetic Disorders of DNA Repair?

References

• Kraemer K H. Progressive degenerative diseases associated with defective DNA repair: xeroderma pigmentosum and ataxia-telangiectasia. DNA Repair Processes, WW Nichols, DG Murphy, Miami 1977; 37–71, Symposium Specialists
   Google Scholar
• Kramer K H. Xeroderma pigmentosum. Clinical Dermatology, DJ Demis. Harper & Row, Hagerstown 1980; 1–33
   Google Scholar
• Kraemer K H. Heritable diseases with increased sensitivity to cellular injury. Update: Dermatology in General Medicine, TB Fitzpatrick, AZ Eisen, K Wolff, IM Freedberg, KF Austen. McGraw-Hill, New York 1983; 113–142
   Google Scholar
• Levin S, Perlov S. Ataxia-telangiectasia in Israel with observations on its relationship to malignant disease. Israel J Med Sci 1971; 12: 1535–1541
   Google Scholar
• Bridges B. How important are somatic mutations and immune control in skin cancer? Reflections on xeroderma pigmentosum. Car-cinogenesis 1981; 2: 471–472
   PubMed Web of Science ®Google Scholar
• Bishop J M. Cellular oncogenes and retroviruses. Ann Rev Biochem 1983; 52: 301–354
   PubMed Web of Science ®Google Scholar
• Klein G. The role of gene dosage and genetic transposition in car-cinogenesis. Nature 1981; 294: 313–318
   PubMed Web of Science ®Google Scholar
• Koulu L, Jansen T. Langerhans cells in xeroderma pigmentosum. J Invest Dermatol 1983; 80: 374
   Web of Science ®Google Scholar
• Potten C S, Allen T D. A model implicating the Langerhans cell in keratinocyte proliferation control. Differentiation 1976; 5: 43–47
   PubMed Web of Science ®Google Scholar
• Streilein J. Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol 1983; 80: 12–16, Suppll
   PubMed Web of Science ®Google Scholar
• Langerhans P. Ueber die Nerven der rnenschlichen Haut. Virchows Arch Pathol Anat Physiol 1868; 44: 325–337
   Google Scholar
• Jimbow K, Sato S, Kukita A. Cells containing Langerhans granules in human lymph nodes of dermatopathic lymphadenitis. J Invest Derrnatol 1969; 53: 295–299
   PubMed Web of Science ®Google Scholar
• Raush E, Kaiserling E, Goos M. Langerhans cells and human dermatopathic lymphadenitis. Virchows Arch (Cell Pathol) 1977; 25: 327–343
   PubMedGoogle Scholar
• Shamoto M, Kaplan C, Katoh A K. Langerhans cell granules in human hyperplastic lymph nodes. Arch Pathol 1971; 92: 46–52
   PubMedGoogle Scholar
• Hoshino Kukita T. A, Sato S. Cells containing Birbeck granules (Langerhans cell granules) in human thymus. J Electron Microsc 1970; 19: 271–276
   PubMedGoogle Scholar
• Hashimoto K, Tarnowski W M. Some new aspects of Langerhans cells. Arch Dermatol 1968; 97: 450–464
   PubMed Web of Science ®Google Scholar
• Vassin T M, Toner P G. Langerhans cells in human oesophagus. J Anal 1976; 122: 435–445
   Google Scholar
• De Geboes K., Wolf-Peeters C, Rutgeerts P. Lymphocytes and Langerhans cells inhuman oesophageal epithelium. Virchows Arch (A) 1983; 401: 45–55
   Web of Science ®Google Scholar
• Löning T, Caselitz J, Seifert G. Identification of Langerhans cells: simultaneous use of sera to intermediate filament, T6 and HLA-DR antigens on oral mucosa of human epidermis and their tumors. Virchows Arch (A) 1982; 398: 119–128
   Web of Science ®Google Scholar
• Daniels T E. Human mucosal Langerhans cells: postmortem identification of regional variations in oral mucosa. J Invest Dermatol 1984; 82: 21–24
   PubMed Web of Science ®Google Scholar
• Tagawa Y, Takeuchi T, Saga T J, Matsuda H. The Langerhans cells in the cornea and conjunctiva: its distribution and Ia antigens. Nippon Ganka Gakkai Zasshi 1982; 86: 825–832
   PubMedGoogle Scholar
• Hazlett L D. Change with age in limbal conjunctival epithelial Langerhans cells. Curr Eye Res 1982/3; 2: 423–425
   PubMed Web of Science ®Google Scholar
• Stingl G, Wolff-Schreiner E C, Pilcher W J. Epidermal Langerhans cells bear F, and C3 receptors. Nature 1977; 268: 245–246
   PubMed Web of Science ®Google Scholar
• Klareskog L, Tjernlund U M, Forsum U, Peterson P A. Epidermal Langerhans cells express Ia antigens. Nature 1977; 268: 248–250
   PubMedGoogle Scholar
• Silverberg-Sinakin I, Thorbecke G J, Baer R L. Antigen-bearing Langerhans cells in skin dermal lymphatics and lymph nodes. Cell Immunol 1976; 25: 137–151
   PubMed Web of Science ®Google Scholar
• Murphy G F, Bhan A K, Sato S. A new immunological marker for human Langerhans cells. N Engl J Med 1981; 304: 791–792
   PubMed Web of Science ®Google Scholar
• Sander D N, Dinarello C A, Morhenn V B. Langerhans cell production of interleukin-l. J Invest Dermatol 1984; 82: 60–607
   Google Scholar
• Stingl G, Katz S I, Green I, Shevach E M. The functional role of Langerhans cells. J Invest Dermatol 1980; 74: 315–318
   PubMed Web of Science ®Google Scholar
• Katz S I, Tamaki K, Sachs D H. Epidermal Langerhans cells are derived from cells originating in the bone marrow. Nature 1979; 282: 324–326
   PubMed Web of Science ®Google Scholar
• Balfour B M, Drexhage H A, Kamperdijk E W, Hoefsrnit E C. Antigen-presenting cells including Langerhans cells, veiled cells and interdigitating cells. Ciba Foundation Symp 1980; 84: 281–301
   Google Scholar
• Tjernlund U, Juhlin L. Effect of uv irradiation on immunological and histochemical markers of Langerhans cells in normal appearing skin of psoriatic patients. Arch Dermatol Res 1982; 272: 171–176
   PubMed Web of Science ®Google Scholar
• Perry L L, Greene M I. Antigen presentation by epidermal Langerhans cells: loss of function following ultraviolet (uv) irradiation in-vivo. Clin Immunol Immunopathol 1982; 24: 204–219
   PubMedGoogle Scholar
• Gurish M F, Lynch D H, Yowell R, Daynes R A. Abrogation of epidermal antigen-presenting cell function by ultraviolet radiation administered in vivo. Transplantation 1983; 36: 304–309
   PubMed Web of Science ®Google Scholar
• Schwartz J L, Weichselbaum R, Frim S R. The effect of aging on the density and distribution of oral mucosal Langerhans cells. Exp Gerontol 1983; 18: 65–71
   PubMed Web of Science ®Google Scholar
• Thiers B H, Maize J C, Spicer S S, Cantor A B. The effect of aging and chronic sun exposure on human Langerhans cell population. J Invest Dermatol 1984; 82: 223–226
   PubMed Web of Science ®Google Scholar
• Morris H H, Gatter K C, Stein H, Mason D Y. Langerhans cells in human cervical epithelium: an immunohistological study. Br J Obstet Gynaecol 1983; 90: 400–411
   PubMedGoogle Scholar
• Bjercke S, Scott H, Braathen L R, Thorsby E. HLA-DR expressing Langerhans-like cells in vaginal and cervical epithelium. Acta Obstet Gynecol Scand 1983; 62: 585–589
   PubMed Web of Science ®Google Scholar
• Koulu L, Jansen T. Epidermal Langerhans cell number and morphology during oral retinoid treatmetn. Arch Dermatol Res 1982; 272: 135–137
   PubMed Web of Science ®Google Scholar
• Kanerva L, Lauharanta J, Niemi K M. Electron microscopic observations of mitotic Langerhans cells as possible sign of retinoid induced stimulation. J Cutan Pathol 1983; 10: 138–143
   PubMed Web of Science ®Google Scholar
• Kobayashi M. Influence of aromatic retinoid on epidermal Langerhans cells. Nippon Hifuka Gakkai Zasshi 1983; 93: 763–771
   PubMedGoogle Scholar
• Fernandez-Bussy R A, Schmidt D, Mauduit G, Thivolet J. Effects of aromatic retinoid (RO 109359) on Langerhans cells in lichen planus. Arch Dermatol Res 1983; 275: 105–108
   PubMed Web of Science ®Google Scholar
• Oguchi M, Komura J, Tagami H, Ofuji S. Ultrastructural studies of spontaneous regressing plane warts show marked activation. Arch Dermatol Res 1981; 271: 55–61
   PubMed Web of Science ®Google Scholar
• Sprecher E, Becker Y. Skin Langerhans cells play an essential role in the defense against HSV-I infections. Arch Virol 1986; 91: 341–349
   PubMed Web of Science ®Google Scholar
• Sprecker E, Becker Y. HSV-I pathogenicity in footpad and ear skin of mice depends on Langerhans cell density, mouse genetics and virus strain. J Virol 1987; 61: 2515–2522
   PubMed Web of Science ®Google Scholar
• Heng M CY, Kloss S G, Kuehn C S, Chase D G. The sequence of events in psoriatic plaque formation after tape stripping. Br J Dermatol 1985; 112: 517–532
   PubMed Web of Science ®Google Scholar
• Sauder D N, Dinarello C A, Morhenn V B. Langerhans cell production of IL-I. J Invest Dermatol 1984; 82: 605–607
   PubMed Web of Science ®Google Scholar
• Bergstresser P R, Fletcher C R, Streilein J W. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunological properties. J Invest Dermatol 1980; 74: 77–80
   PubMed Web of Science ®Google Scholar
• Warner T F, Raa Hafez G. Langerhans cell tumor of the eyelid. J Cutan Pathol 1982; 9: 417–422
   PubMed Web of Science ®Google Scholar
• Shamoto M. Langerhans cells increase in dermal lesions of adult T cell leukemia in Japan. J Clin Pathol 1983; 36: 307–311
   PubMed Web of Science ®Google Scholar
• Galter K C, Morris H B, Roach B. Langerhans cells and T cells in human skin tumors: an immunohistological study. Histopathology 1984; 8: 229–244
   PubMed Web of Science ®Google Scholar
• Uchiyama T, Yodoi J, Sagawa K. Adult T-cell leukemia: clinical and hematological features of 16 cases. Blood 1977; 50: 481–492
   PubMed Web of Science ®Google Scholar
• Shamoto M, Murakami S, Zenke T. Adult T-cell leukemia in Japan: an ultrastructural study. Cancer 1981; 47: 1804–1811
   PubMed Web of Science ®Google Scholar
• Van Der Loo E M, Van Muijen G NP, Van Vloten W A. C-type virus-like particles specifically localized in Langerhans cells and related cells of skin and lymph nodes of patients with mycosis fungoides and szary syndrome. A morphological and biochemical study. Virchows Arch (Cell Pathol) 1979; 31: 193–203
   Google Scholar
• Chu A, Berger C L, Kung P, Edelson R L. In situ identification of Langerhans cells in the dermal infiltrate of cutaneous T cell lymphoma. J Am Acad Dermatol 1982; 6: 350–354
   PubMed Web of Science ®Google Scholar
• Ryan E A, Sanderson K V, Bartak P, Samman P D. Can mycosis fungoides begin in the epidermis: a hypothesis. Br J Dermatol 1973; 88: 419–429
   PubMed Web of Science ®Google Scholar
• Rowden G, Lewis M G. Langerhans cells: involvement in the pathogenesis of mycosis fungoides. Br J Dermatol 1976; 95: 665–672
   PubMed Web of Science ®Google Scholar
• Rowden G, Phillips T M, Lewis M G, Silkinson R D. Target role of Langerhans cells in mycosis fungoides: transmission and immunoelectron microscopic studies. J Cutan Pathol 1979; 6: 364–382
   PubMed Web of Science ®Google Scholar
• Schmitt D, Thivolet J. Lymphocyte epidermis interactions in malignant epidermotropic lymphomas. I. Ultrastructural aspects. Acta Derm Venereal (Stochk) 1980; 60: 1–11
   PubMed Web of Science ®Google Scholar
• Hinuma Y, Nagata K, Hanaoka M. Adult T cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci (USA) 1981; 78: 6476–6480
   PubMed Web of Science ®Google Scholar
• Gallo R C, Mann D, Broder S. Human T-cell leukemia-lymphoma virus (HTLV) is in T but not B lymphocytes from a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci (USA) 1982; 79: 5680–5683
   PubMed Web of Science ®Google Scholar
• Gallo R C. HTLV: the first human retroviruses (leukemia viruses) and their role in human malignancies. Accomplishments in Cancer Research, JG Fortner, JE Rhodas. General Motors Cancer Research Foundation. 1983, prize year
   Google Scholar
• Saito T, Honma T, Saigo K. Epidermal Langerhans cells after the prick test for Behcet's disease. Dermatologica 1980; 161: 152–156
   PubMedGoogle Scholar
• Kohn S, Haim S, Gilhar A. Epidermal Langerhans cells in Behcet's disease. J Clin Pathol 1984; 37: 616–619
   PubMed Web of Science ®Google Scholar
• Belsito D V, Sanchez M R, Baer R L. Reduced Langerhans cell la antigen and ATPase activity in patients with the acquired immunodeficiency syndrome. N Engl J Med 1984; 310: 1279–1282
   PubMed Web of Science ®Google Scholar
• Human T-cell Leukemia/Lymphoma Virus, RC Gallo, ME Essex, L Gross. Cold Spring Harbor Laboratory, Cold Spring Harbor 1984
   Google Scholar
• Robbins J H. Xwoderma pigmentosum (NIH Conference). Ann Intern Med 1974; 80: 221–248
   PubMed Web of Science ®Google Scholar
• Setlow R B. Repair-deficient human disorders and cancer. Nature 1978; 271: 713–717
   PubMed Web of Science ®Google Scholar
• Arlett C F, Lehmann A R. Human disorders showing increased sensitivity to the induction of genetic damage. Ann Rev Genet 1978; 12: 95–115
   PubMed Web of Science ®Google Scholar
• Paterson M C. Environmental carcinogenesis and imperfect repair of damaged DNA in Homo sapiens: causal relationship revealed by rare hereditary disorders. Carcinogens: Identification and Mechanism of Action, AC Griffin, CR Shaw. Raven Press, New York 1979; 251–276
   Google Scholar
• Weichselbaum R R, Nove J, Little J B. X-ray sensitivity of fifty-three human diploid fibroblast cell strains from patients with characterized genetic disorders. Cancer Res 1980; 40: 920–925
   PubMed Web of Science ®Google Scholar
• Becker Y, Shaham M, Tabor E, Shiloh Y. Ataxia-telangiectasia—a human autosomal recessive disorder predisposing to cancer. The Role of Viruses in Human Cancer. Vol. II, G Giraldo, E Beth. Elsevier/North Holland, Amsterdam 1984; 397–406
   Google Scholar
• Becker Y, Shaham M, Shiloh Y, Voss R. Chromosome breakage and sensitivity to DNA breaking agents in ataxia-telangiectasia and their possible association with predisposition to cancer. Biochemical and Biological Markers of Neoplastic Transformation, NATO Advanced Study Institute. Corfu Island, Greece, 1981. Plenum Press, New York 1983; 171–184
   Google Scholar
• Shiloh Y, Tabor E, Becker Y. Cellular hypenensitivity to neocar-zinostatin in ataxia-telangiectasia skin fibroblasts. Cancer Res 1982; 42: 2247–2249
   PubMed Web of Science ®Google Scholar
• Shiloh Y, Tabor E, Becker Y. The response of ataxia-telangiectasia homozygous and heterozygous skin fibroblasts to neocarzinostatin. Carcinogenesis 1982; 3: 815–820
   PubMed Web of Science ®Google Scholar
• Shiloh Y, Tabor E, Becker Y. Repair of potentially lethal and sublethal damage induced by neocarzinostatin in normal and ataxia-telangiecrasia skin fibroblasts. Biochem Biophys Res Comm 1983; 110: 483–490
   PubMed Web of Science ®Google Scholar
• Thorbecke G J, Silberberg-Sinakin I, Flotte I G. Langerhans cells as macrophages in skin and lymphoid organs. J Invest Dermatol 1980; 75: 32–43
   PubMed Web of Science ®Google Scholar
• Burnet F M. Differentiation and somatic mutation. Immuno-logical Surveillance. Pergamon Press, New York 1970; 50
   Google Scholar
• Swift M, Sholman L, Perry M, Chase C. Malignant neoplasrns in the families of patients with ataxla-telangiectasia. Cancer Res 1976; 36: 209–215
   PubMed Web of Science ®Google Scholar
• Sasaki M S, Tommura A. A high wsceptibility of Fanconi's anemia to chromosome breakage by DNA crosslinking agents. Cancer Res 1973; 33: 1829–1836
   PubMed Web of Science ®Google Scholar
• Fanconi G. Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.). I. Clinical aspects. Sem Hematol 1967; 4: 233–240
   PubMedGoogle Scholar
• Schroeder T M, Tilgen D, Kruger J, Vogel F. Formal genetics of Fanconi's anemia. Hum Genet 1976; 32: 257–288
   PubMed Web of Science ®Google Scholar
• Alter B P, Potter N U. Long-term outconie in Fanconi's anemia: Description of 26 cases and review of the literature. In. Chromosome Mutation and Neoplasia, J German. Alan R Liss, New York 1983; 43–62
   Google Scholar
• Swift M. Fanconi's anemia in the genetics of neoplasia. Nature 1971; 230: 370–373
   PubMed Web of Science ®Google Scholar
• Sasaki M S. Fanconi's anemia. A condition possibly associated with a defective DNA repair. DNA Repair Mechanisms, PC Hanawalt, EC Friedberg, CF Fox. Academic Press, New York 1978; 675–683
   Google Scholar
• Auerbach A D, Wolman S R. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 1976; 261: 494–496
   PubMed Web of Science ®Google Scholar